Skip to content
Science

Center for Disease Analysis Foundation Receives $7 Million Grant from the John C. Martin Foundation to Support the Polaris Observatory

Center for Disease Analysis Foundation 2 mins read
LAFAYETTE, Colo.--BUSINESS WIRE--

The Center for Disease Analysis (CDA) Foundation is pleased to announce receipt of a $7 million grant from the John C. Martin Foundation to sustain and expand the Polaris Observatory until the end of 2030.

The Polaris Observatory serves as the definitive source for global data on hepatitis B and C virus (HBV and HCV) burden, providing insights into the prevalence and distribution of these viruses across countries, regions, and globally. It also assists national governments and international organizations in monitoring progress toward the World Health Organization’s (WHO) 2030 elimination targets for HBV and HCV. Annually, the Observatory collaborates with over 1,000 national experts in 120 countries, updating forecasts for each country. Additionally, it offers pro bono support to national governments, assisting them in developing and implementing elimination programs and strategies to fund for their initiatives.

“We are deeply grateful for the John C. Martin Foundation’s unwavering support,” expressed Homie Razavi, Managing Director of the CDA Foundation. “Their initial funding in 2015 catalyzed the establishment of the Polaris Observatory, and their continuous support has enabled us to sustain our work. The Observatory’s programs are supported by a dedicated team of epidemiologists, mathematical modelers, programmers, and decision analysts. The Observatory’s contributions have resulted in nationally funded access to hepatitis screening for 1.7 billion people globally, laboratory testing (24 million people), and treatment (19 million people) as result of recognized value of early detection and treatment. This new grant will facilitate our continued efforts through 2030.”

“On behalf of the John C. Martin Foundation, it is a privilege to support the CDA Foundation in the past decade to service the international hepatitis elimination collaborators. We are grateful for the opportunity to support such an impactful and momentous program,” said Dr. Lillian Lou, President, Program Director of the John C. Martin Foundation (https://thejcmfoundation.org).

CDA Foundation is a nonprofit organization focused on accelerating hepatitis B and C elimination through verified epidemiological data, disease burden and economic impact modeling, intervention strategies, innovative financing, and knowledge-sharing partnerships. It accomplishes these goals through the Polaris Observatory (https://cdafound.org/polaris/).


Contact details:

Media Contact:
Homie Razavi
(T) +1 720.890.4848
hrazavi@cdafound.org

Media

More from this category

  • Science
  • 14/11/2024
  • 10:40
WEHI

All in the blood: new way to detect drug resistance in ovarian cancer patients

WEHIresearchers have found a new way to predict a subset of patients who are likely to become resistant to PARP inhibitors (PARPi), a key…

  • Contains:
  • Science
  • 14/11/2024
  • 10:38
Monash University

Stardust clues show Sun took 10-20 million years to form

Stardust left behind from the dawn of our solar system has allowed scientists to estimate the Sun took between 10 and 20 million years to form. While there is consensus the Sun formed about 4.6 billion years ago from a molecular cloud of gas and dust, less was known about how long the formation took. The findings were published today in the prestigious scientific journal Nature and relied on tools pioneered by Monash University astrophysicists led by Associate Professor Amanda Karakas. Dr Karakas said the tools, called stellar evolution models, allow scientists to calculate how the chemical composition changes when…

  • Medical Health Aged Care, Science
  • 13/11/2024
  • 07:24
La Trobe University

Space mission explores role of gravity in health

La Trobe University has joined a space mission from Sweden as part of an international collaboration with the German space agency and a Melbourne aerospace engineering firm to explore the role of gravity for health and disease in space and on Earth. A tiny vial of "flying gut cells" on board the MAPHEUS-15 research rocket, which launched on 11 November, will give scientists a better understanding of how the removal of gravity in long-term space flight affects the body. This is critical not only for the health of astronauts but could also have implications for medical advances on Earth. Coordinated…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.